Timothy Robinson, MD, PhD

home / authors / timothy-robinson-md-phd

Articles

No evidence indicates synergistic toxicity when combining radiation with CAR T-cell therapy in this population, according to Timothy Robinson, MD, PhD.

Radiotherapy/CAR T Combo May be “Great Option” in Relapsed/Refractory DLBCL

October 13th 2024

No evidence indicates synergistic toxicity when combining radiation with CAR T-cell therapy in this population, according to Timothy Robinson, MD, PhD.

The addition of radiotherapy to CAR T-cell therapy may particularly benefit patients with localized disease, according to Timothy Robinson, MD, PhD.

Bridging Radiation and CAR T-cell Therapy May Have Benefit in Relapsed/Refractory DLBCL

Timothy Robinson, MD, PhD

October 12th 2024

The addition of radiotherapy to CAR T-cell therapy may particularly benefit patients with localized disease, according to Timothy Robinson, MD, PhD.

$Timothy Robinson, MD, PhD, discusses how radiation may play a role as bridging therapy to CAR T-cell therapy for patients with relapsed/refractory DLBCL.$

Getting to the CAR T-cell Therapy Starting Line With Radiotherapy in R/R DLBCL

Timothy Robinson, MD, PhD

October 11th 2024

Timothy Robinson, MD, PhD, discusses how radiation may play a role as bridging therapy to CAR T-cell therapy for patients with relapsed/refractory DLBCL.